Richard C.K. Jordan, DDS, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Richard C.K. Jordan, DDS, PhD

Professor, Departments of Orofacial Sciences and Pathology, UCSF

rckj@itsa.ucsf.edu

Phone: (415) 476-8233 (voice)
Box 0424, UCSF
San Francisco, CA 94143-0424

View on UCSF Profiles

Cancer Center Membership

Associate Member ยป Cancer Genetics

Education

University of Toronto, D.D.S., 1986, Dentistry
University of Toronto, M.Sc., 1992, Oral Pathology
University of London (UK), Ph.D., 1995, Experimental Pathology


Professional Experience

  • 1986-1987
    Intern; Toronto Western Hospital, Toronto, Canada
  • 1987-1988
    General dental practice; Newmarket, Ontario, Canada
  • 1988-1989
    Resident in anatomic pathology; Toronto Western Hospital, Toronto, Canada
  • 1989-1991
    Resident in Oral Pathology; University of Toronto
  • 1991
    Research Fellow; Canadian Reference Centre for Cancer Pathology, Ottawa, Canada
  • 1992-1995
    Medical Research Council of Canada Research Fellow, U. London, London, UK
  • 1994
    Research Fellow; Department of Haematology; Kanazawa Medical University, Kanazawa, Japan
  • 1995-2000
    Oral Pathologist; Sunnybrook & Women's College Health Sciences Centre, Toronto, Canada
  • 1995-2000
    Assistant Professor; Faculty of Dentistry, University of Toronto
  • 1995-2000
    Assistant Professor, Faculty of Medicine, Dept. of Lab Medicine & Pathobiology, University of Toronto
  • 2000-2001
    Associate Professor, Faculty of Dentistry, University of Toronto
  • 2001-present
    Professor & Vice Chair, Department of Orofacial Sciences & Department of Pathology, UCSF

Honors & Awards

  • 1981
    Senate Scholarship, U. Western Ontario
  • 1985
    Wroblewski Award; Mosby Prize; Murray Cornish Scholarship
  • 1986
    Xi Xsi Phi prize; Deans Honour List
  • 1991
    U. Toronto Open Fellowship; Canadian Fund for Dental Education Award
  • 1994
    International Association of Oral Pathology Award
  • 1995
    International Association for Dental Research prize in Experimental Pathology

Selected Publications

  1. White lesions in the oral cavity: clinical presentation, diagnosis, and treatment. Semin Cutan Med Surg. 2015 Dec; 34(4):161-70.
    View on PubMed
  2. Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity. J Clin Oncol. 2014 Dec 1; 32(34):3858-67.
    View on PubMed
  3. Oral mucus extravasation phenomenon with myxoglobulosis. J Cutan Pathol. 2014 Oct; 41(10):767-70.
    View on PubMed
  4. p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma. J Clin Oncol. 2014 Dec 10; 32(35):3930-8.
    View on PubMed
  5. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol. 2014 Sep 20; 32(27):2940-50.
    View on PubMed
  6. Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234. J Clin Oncol. 2014 Aug 10; 32(23):2486-95.
    View on PubMed
  7. Ossifying fibroma in Buschke-Ollendorff syndrome. J Cutan Pathol. 2014 Sep; 41(9):740-4.
    View on PubMed
  8. Loss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jan; 115(1):95-103.
    View on PubMed
  9. Discovery of specific ligands for oral squamous carcinoma to develop anti-cancer drug loaded precise targeting nanotherapeutics. J Calif Dent Assoc. 2012 Dec; 40(12):939-43.
    View on PubMed
  10. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 2013 Jan; 49(1):1-8.
    View on PubMed
  11. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol. 2012 Jul; 36(7):945-54.
    View on PubMed
  12. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol. 2012 Jun 10; 30(17):2102-11.
    View on PubMed
  13. 20q- clonality in a case of oral sweet syndrome and myelodysplasia. Am J Clin Pathol. 2012 Feb; 137(2):310-5.
    View on PubMed
  14. Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J Infect Dis. 2012 Feb 1; 205(3):458-65.
    View on PubMed
  15. Clinical signs and histologic findings in dogs with odontogenic cysts: 41 cases (1995-2010). J Am Vet Med Assoc. 2011 Dec 1; 239(11):1470-6.
    View on PubMed
  16. Giant cell lesions of the jaws: does the level of vascularity and angiogenesis correlate with behavior? J Oral Maxillofac Surg. 2012 Aug; 70(8):1860-6.
    View on PubMed
  17. Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis. Clin Cancer Res. 2011 Nov 15; 17(22):7024-34.
    View on PubMed
  18. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011 Nov 10; 29(32):4294-301.
    View on PubMed
  19. Soft tissue tumors and common metastases of the oral cavity. Periodontol 2000. 2011 Oct; 57(1):177-97.
    View on PubMed
  20. Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer. Cancer. 2012 Feb 15; 118(4):1007-13.
    View on PubMed

Go to UCSF Profiles, powered by CTSI